GKB Ophthalmics Ltd.
Snapshot View

74.20 +1.55 ▲2.1%

24 June 2022, 04:01:00 PM
Volume: 155

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.gkb.net
Market Cap 37.40 Cr.
Enterprise Value(EV) 32.76 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.53 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 29.36 Trailing Twelve Months Ending 2022-03
Industry PE 42.47 Trailing Twelve Months Ending 2022-03
Book Value / Share 125.18 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.59 Calculated using Price: 74.20
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.50 Cr. 5,040,580 Shares
FaceValue 10
Company Profile
The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+2.13%
1 Week
+2.27%
1 Month
+2.20%
3 Month
-13.17%
6 Month
-14.22%
1 Year
-28.55%
2 Year
+18.25%
5 Year
-52.13%
10 Year
+105.54%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -3.10 6.60 -3.30 9.32 5.65 -2.12 -2.52 -4.41 -2.25
Return on Capital Employed (%) 3.36 14.52 0.82 18.94 7.99 0.25 -0.34 -1.38 0.65
Return on Assets (%) -1.52 3.39 -1.78 5.48 3.34 -1.15 -1.36 -2.41 -1.29

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 35 40 40 45 47 45 55 59 63 63
Non Curr. Liab. 4 3 2 2 2 2 5 5 2 3
Curr. Liab. 34 30 33 23 37 36 37 41 38 40
Minority Int. 4 4
Equity & Liab. 73 73 75 69 86 83 97 106 107 110
Non Curr. Assets 27 29 29 18 19 19 33 33 33 35
Curr. Assets 45 43 46 51 66 64 64 73 74 76
Misc. Exp. not W/O
Total Assets 73 73 75 69 86 83 97 106 107 110

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 43 41 35 44 74 77 57 59 57 71
Other Income 1 1 1 2 1 0 2 1 2 1
Total Income 43 42 36 46 75 78 59 59 59 72
Total Expenditure -40 -34 -34 -46 -72 -76 -56 -56 -55 -66
PBIDT 4 8 1 0 3 2 3 3 4 6
Interest -3 -3 -3 -2 -1 -1 -1 -1 -2 -1
Depreciation -1 -1 -2 -1 -1 -2 -4 -4 -3 -3
Taxation 0 -2 1 -4 0 0 0 0
Exceptional Items -1 0 1 11 3 -1
PAT -1 2 -1 4 3 -1 -1 -2 -1 2
Minority Interest 0 -1
Share Associate 0 2 1 0 1 1 0
Other Related Items 0
Consolidated Net Profit -1 4 4 3 -1 -1 -2 -1 1
Adjusted EPS -2 10 0 10 6 -2 -2 -4 -2 3

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 3 3 6 7 -11 -3 -3 4 3 -4
Cash Fr. Inv. -5 -2 -2 -1 15 4 1 -10 -4 -6
Cash Fr. Finan. 2 -1 -5 -6 -3 -1 1 13 4 3
Net Change 0 1 0 1 0 -1 0 7 4 -7
Cash & Cash Eqvt 2 2 2 3 3 2 2 9 13 6

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 48.97 48.98 49.04 49.52 59.44 59.24 59.58 59.69 59.72
Public 51.03 51.02 50.96 50.48 40.56 40.76 40.42 40.31 40.28
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 14 Jun 2022
Submission Of Consolidated Related Party Transactions As On March 31 2022.
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 enclosed please find disclosure of Related Party Transactions on consolidated basis for the half year ended March 31 2022.Kindly take the information on record.
Fri, 10 Jun 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that our Registrar & Transfer Agent (RTA) Link Intime India Pvt. Ltd. has received a request letter from Mr. Abraham Mathew Manthara shareholder regarding loss of share certificate and request for issue of duplicate thereof. A copy of the email intimation received from our RTA on 09/06/2022 is enclosed herewith.Kindly note that our RTA has initiated process for issuance of duplicate share certificates in lieu thereof subject to compliance of the required formalities.You are requested to take note of the aforesaid information.
Thu, 02 Jun 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of newspaper cuttings of the extract of Statement of audited Standalone and Consolidated Financial Results for the year ended March 31 2022 published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated June 01 2022.Please acknowledge receipt.

Technical Scans View Details

Fri, 24 Jun 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 3 Months High Decrease 3 Months
Close Crossing 20 EMA From Below Close Crossing 20 EMA From Below

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 197,729.19 824.10 -0.1%
Divi's Laboratories Ltd. 97,465.46 3,671.45 +0.1%
Cipla Ltd. 75,288.48 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. 71,702.79 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. 55,150.04 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. 48,693.19 2,877.70 +0.8%
Gland Pharma Ltd. 42,987.55 2,610.75 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 60.42 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 32.92 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 29.92 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.85 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 52.24 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.67 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 35.48 2,610.75 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.12 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.31 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 3.61 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.73 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.78 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.18 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 6.01 2,610.75 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 0.10 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 19,159.59 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,610.75 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 2,401.30 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,610.75 +0.1%

FAQ's On GKB Ophthalmics Ltd.

Can I Buy GKB Ophthalmics Shares now?

What is the Share Price of GKB Ophthalmics?

What is the Relative Strength Index (RSI) Value of GKB Ophthalmics?

What is the Market Capital (MCAP) of GKB Ophthalmics?

What are the key metrics to analyse GKB Ophthalmics?

What is the Price Performance of GKB Ophthalmics?